Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Gastric adenocarcinoma case treated with capecitabine and trastuzumab. After surgery, a G2 neuroendocrine tumor was found.
Conference:
Presenting Author:
Authors: Jimenez Gordo A, Gomez Raposo C, Garcia-Sancho Tellez L, Salinas Moreno S, Madrid Vallenilla A,
Keywords: MiNEN, clonal selection, citostatic treatment,
#4044 18 F-DOPA PET/CT leading to diagnosis of micro pheochromocytoma
Introduction: Pheochromocytomas are rare neuroendocrine tumors arising from the chromaffin cells of the adrenal medulla. The recent revision in the WHO classification of Endocrine Tumors 2022 has replaced the historical term "nodular hyperplasia" with "micro pheochromocytoma," owing to the presence of similar molecular clonal changes as larger tumors.
Conference:
Presenting Author:
Authors: Roman-Gonzalez A, Arias L, Castellano A, Toro J, Vega I,
Keywords: Pheochromocytoma, PET-CT, Paraganglioma, NGS,
Introduction: There is an increasing interest in the role of sex and gender in cancer patients. The impact of sex differences in systemic oncological therapies is still unknown, and there is a lack of evidence, especially in uncommon neoplasms like neuroendocrine tumors (NET).
Conference:
Presenting Author:
Authors: Hernando Cubero J, Roca-Herrera M, Garcia Alvarez A, Raymond E, Kulke M,
Keywords: Sex, Toxicity, Tyrosine Kinase Inhibitor,
Introduction: Glucagonomas are rare neuroendocrine tumors (NETs), generally diagnosed with locoregional involvement; it has heterogeneous survival with therapeutic approaches ranging from the use of somatostatin analogues, and cytoreductive surgery to PRRT.
Conference:
Presenting Author:
Authors: González Devia D, Rozo-Paz G, Chalela-Mantilla J, Aguirre Matallana D, Arias Amézquita F,
Keywords: Glucagonoma, Migratory necrolytic erythema, Octreotide, Overall survival, Neuroendocrine tumor,
Introduction: The importance of timely assistance in oncological patients is undeniable; however it is well known that these patients could have important clinical problems if they were infected by COVID-19, with an increased risk of severe illness and mortality. A recent multicenter Italian study reported a delay both in the beginning of PRRT for new patients and in those ones who had already started the treatment, as a direct consequence of COVID-19.
Conference:
Presenting Author: Grana C